Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2
Reut Falach, Liat Bar-On, Shlomi Lazar, Tamar Kadar, Ohad Mazor, Moshe Aftalion, David Gur, Yentl Evgy, Ohad Shifman, Tamar Aminov, Ofir Israeli, Inbar Cohen-Gihon, Galia Zaide, Hila Gutman, Yaron Vagima, Efi Makdasi, Dana Stein, Ronit Rosenfeld, Ron Alcalay, Eran Zahavy, Haim Levy, Itai Glinert, Amir Ben-Shmuel, Tomer Israely, Sharon Melamed, Boaz Politi, Hagit Achdout, Shmuel Yitzhaki, Chanoch Kronman, Tamar Sabo
Reut Falach, Liat Bar-On, Shlomi Lazar, Tamar Kadar, Ohad Mazor, Moshe Aftalion, David Gur, Yentl Evgy, Ohad Shifman, Tamar Aminov, Ofir Israeli, Inbar Cohen-Gihon, Galia Zaide, Hila Gutman, Yaron Vagima, Efi Makdasi, Dana Stein, Ronit Rosenfeld, Ron Alcalay, Eran Zahavy, Haim Levy, Itai Glinert, Amir Ben-Shmuel, Tomer Israely, Sharon Melamed, Boaz Politi, Hagit Achdout, Shmuel Yitzhaki, Chanoch Kronman, Tamar Sabo
View: Text | PDF
Research Article COVID-19

Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2

  • Text
  • PDF
Abstract

Mice are normally unaffected by SARS coronavirus 2 (SARS-CoV-2) infection since the virus does not bind effectively to the murine version of the angiotensin-converting enzyme 2 (ACE2) receptor molecule. Here, we report that induced mild pulmonary morbidities rendered SARS-CoV-2–refractive CD-1 mice susceptible to this virus. Specifically, SARS-CoV-2 infection after application of low doses of the acute lung injury stimulants bleomycin or ricin caused severe disease in CD-1 mice, manifested by sustained body weight loss and mortality rates greater than 50%. Further studies revealed markedly higher levels of viral RNA in the lungs, heart, and serum of low-dose ricin–pretreated mice compared with non-pretreated mice. Furthermore, lung extracts prepared 2–3 days after viral infection contained subgenomic mRNA and virus particles capable of replication only when derived from the pretreated mice. The deleterious effects of SARS-CoV-2 infection were effectively alleviated by passive transfer of polyclonal or monoclonal antibodies generated against the SARS-CoV-2 receptor binding domain (RBD). Thus, viral cell entry in the sensitized mice seems to depend on viral RBD binding, albeit by a mechanism other than the canonical ACE2-mediated uptake route. This unique mode of viral entry, observed over a mildly injured tissue background, may contribute to the exacerbation of coronavirus disease 2019 (COVID-19) pathologies in patients with preexisting morbidities.

Authors

Reut Falach, Liat Bar-On, Shlomi Lazar, Tamar Kadar, Ohad Mazor, Moshe Aftalion, David Gur, Yentl Evgy, Ohad Shifman, Tamar Aminov, Ofir Israeli, Inbar Cohen-Gihon, Galia Zaide, Hila Gutman, Yaron Vagima, Efi Makdasi, Dana Stein, Ronit Rosenfeld, Ron Alcalay, Eran Zahavy, Haim Levy, Itai Glinert, Amir Ben-Shmuel, Tomer Israely, Sharon Melamed, Boaz Politi, Hagit Achdout, Shmuel Yitzhaki, Chanoch Kronman, Tamar Sabo

×

Figure 4

SARS-CoV-2 binding and injury in lungs of LDR mice.

Options: View larger image (or click on image) Download as PowerPoint
SARS-CoV-2 binding and injury in lungs of LDR mice.
(A–C) Histology: nai...
(A–C) Histology: naive (A) and LDR (B and C) mice (ricin application at day –2) were subjected to SARS-CoV-2 infection at a dose of 5 × 106 PFU/mouse. Lungs at the time of viral infection (day 0) and 7 days later were harvested, fixed, and processed for paraffin embedding. Sections (5 μm) were stained with H&E for general histopathology (A and B) or with Masson’s trichrome (MTC) for collagen (C). Representative sections of n = 4 mice are shown. Indicated are perivascular and peribronchial inflammation (stars), infiltration in perivascular and alveolar sites (triangles), edema (arrows), and fibrin (hashtags). Magnification ×20, scale bar: 100 μm. (D and E) Confocal microscopy scans of lung sections. (D) Sections from LDR mice (lungs harvested 2 days after LDR administration) and naive mice were incubated with SARS-CoV-2 (1000 PFU/mL), immunostained with a mAb directed against the spike region of SARS-CoV-2, and then visualized by AF594-labeled anti-human antibody. Staining of SARS-CoV-2 in red and identification of nuclei by DAPI in blue, scale bar: 50 μm (see also Supplemental Figure 3). Representative sections of n = 4 mice are shown. (E) Scatterplots of the fluorescence staining intensities of SARS-CoV-2 expressed as MFI ± SEM, n = 4 mice, 5 scanned fields/lung, analyzed using unpaired t test. ***P <0.001. Abbreviation: dpi, days after infection.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts